Evercore Oracle · ORCL

Evercore ISI Reiterates Outperform on Oracle, $245 Price Target

1 min read Reproduced verbatim
Rating
Outperform
Unchanged
Target
$245
Unchanged
Upside
+113%
ORCL at $115 today
Evercore and Oracle logos

What the analyst said

Evercore ISI analyst Kirk Materne reiterated an Outperform rating and $245.00 price target on Oracle (NYSE: ORCL).

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $245 target is 5% above the median.

Since the note ORCL has moved −30% (from $165). 12-month window: day 134 of 365, closes on June 24, 2027.

Track record

This callOpen: ORCL has not reached $245 yet. This 12-month target is scored on June 8, 2027. Same target as this firm’s June 8, 2026 note, so it is scored there.

Firm track recordEvercore: 88% of its 16 targets at least a year old were reached within 12 months (#3 of 26 firms). Accuracy ranking →

Evercore on Oracle

Evercore price targets on Oracle

3 calls from March 11, 2026 to June 24, 2026. The target went from $220 to $245 (+11%). The rating stayed Buy.

Evercore targetORCL share price
  1. June 24, 2026 This noteKept the $245 targetBuy$245
  2. June 8, 2026Target raised from $220 (+11%)Buy$245
  3. March 11, 2026Earliest call shownBuy$220
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.